also known acid synthetic steroidal orally active antiestrogen development treatment estrogen receptor erpositive metastatic breast drug silent antagonist erÎ± nm well selective estrogen receptor degrader analogue fulvestrant hydroxyl group replaced boronic acid accordance two drugs similar pharmacodynamic however whereas fulvestrant orally active must administered via intramuscular injection less susceptible firstpass metabolism relation orally single oral dose mgkg mice found result ngml pgml maximal concentration drug circulation level far excess ngml pgml concentration achieved subcutaneous injection fulvestrant may convenient administer humans far greater bioavailability compared fulvestrant hence may allow greater systemic exposure therapeutic produces fulvestrant active metabolite vivo mice approximately drug converted effects likely due parent december phase clinical trial metastatic breast article steroid stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding